Chronological development of in-patient oncology in times of COVID-19: a retrospective analysis of hospitalized oncology and COVID-19 patients of a German University Hospital.
COVID-19
Lockdown
Oncology
University hospital
Virus variants
Journal
Journal of cancer research and clinical oncology
ISSN: 1432-1335
Titre abrégé: J Cancer Res Clin Oncol
Pays: Germany
ID NLM: 7902060
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
04
04
2022
accepted:
26
04
2022
medline:
27
4
2023
pubmed:
1
7
2022
entrez:
30
6
2022
Statut:
ppublish
Résumé
The goal of this study is to examine the chronological development of hospitalized oncology and COVID-19 patients, and compare effects on oncology sub-disciplines for pre-pandemic (2017-19) and pandemic (2020-21) years in the setting of a German university maximum care provider. Data were retrospectively retrieved from the hospital performance controlling system for patient collectives with oncological main (n The oncology patient collective (n The results confirm a decline in hospitalized oncology patients for the entire pandemic in the setting of a maximum care provider. Imposed lockdown and contact restrictions, rising COVID-19 case numbers, as well as discovery of new virus variants have a negative impact on hospitalized treated oncological patients.
Identifiants
pubmed: 35771262
doi: 10.1007/s00432-022-04044-8
pii: 10.1007/s00432-022-04044-8
pmc: PMC9244885
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2551-2558Informations de copyright
© 2022. The Author(s).
Références
ESMO Open. 2021 Aug;6(4):100197
pubmed: 34474811
Cancers (Basel). 2021 Jan 22;13(3):
pubmed: 33499223
BMJ. 2021 Jan 22;372:n83
pubmed: 33483336
J Natl Cancer Inst. 2021 Nov 2;113(11):1484-1494
pubmed: 34258611
Clin Exp Dermatol. 2021 Jan;46(1):145-146
pubmed: 32754962
JCO Clin Cancer Inform. 2020 Nov;4:1059-1071
pubmed: 33253013
J Cancer Res Clin Oncol. 2022 Nov;148(11):3117-3123
pubmed: 35041059
Viruses. 2022 Jan 30;14(2):
pubmed: 35215887
Dtsch Arztebl Int. 2020 Dec 21;117(51-52):886-887
pubmed: 33637170
BJUI Compass. 2022 Jan 27;3(4):277-286
pubmed: 35783588
Dtsch Arztebl Int. 2021 Oct 1;118(39):660-661
pubmed: 34919047
Lancet Child Adolesc Health. 2020 May;4(5):e10-e11
pubmed: 32278365
Lancet Oncol. 2021 Nov;22(11):1507-1517
pubmed: 34624250
Mayo Clin Proc Innov Qual Outcomes. 2021 Dec;5(6):1109-1117
pubmed: 34693211
Dtsch Arztebl Int. 2021 May 7;118(18):328-329
pubmed: 34140084
MedComm (2020). 2021 Oct 19;2(4):846-854
pubmed: 34909755
Cancers (Basel). 2021 Jun 28;13(13):
pubmed: 34203185
Lancet Respir Med. 2022 Feb;10(2):e17
pubmed: 34929158
Int J Gynecol Cancer. 2020 Nov;30(11):1667-1671
pubmed: 33033166
JAMA Netw Open. 2021 Sep 1;4(9):e2126334
pubmed: 34546368
MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1250-1257
pubmed: 32915166
Eur Arch Otorhinolaryngol. 2022 Feb;279(2):961-965
pubmed: 33929609
Lancet Reg Health West Pac. 2021 May;10:100127
pubmed: 33778794
Oncol Res Treat. 2021;44(3):71-75
pubmed: 33333506
Br J Dermatol. 2020 Oct;183(4):792-794
pubmed: 32500571
Int J Radiat Oncol Biol Phys. 2021 Oct 1;111(2):331-336
pubmed: 34004229
Lancet Reg Health Eur. 2021 Oct;9:100188
pubmed: 34514453